Cargando…

Conservative Iron Chelation for Neuroferritinopathy

BACKGROUND: Neuroferritinopathy is a rare inherited neurodegenerative disease with brain iron accumulation characterized by brain iron overload resulting in progressive movement disorders. No treatment is currently available. OBJECTIVE: We assessed conservative iron chelation with deferiprone at 30 ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchand, Felix, Moreau, Caroline, Kuchcinski, Gregory, Huin, Vincent, Defebvre, Luc, Devos, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360136/ https://www.ncbi.nlm.nih.gov/pubmed/35996824 http://dx.doi.org/10.1002/mds.29145

Ejemplares similares

Neuroferritinopathy: iron in the brain
por: Burn, John
Publicado: (2014)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015)

MRI Findings in Neuroferritinopathy
por: Ohta, Emiko, et al.
Publicado: (2012)

Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease
por: Coku, Ilda, et al.
Publicado: (2022)

Texture-based markers from structural imaging correlate with motor handicap in Parkinson’s disease
por: Betrouni, Nacim, et al.
Publicado: (2021)

Behavioral Characterization of Mouse Models of Neuroferritinopathy
por: Capoccia, Sara, et al.
Publicado: (2015)

Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation
por: Devos, David, et al.
Publicado: (2009)

FTL mutation in a Chinese pedigree with neuroferritinopathy
por: Ni, Wang, et al.
Publicado: (2016)

Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management
por: Kumar, Niraj, et al.
Publicado: (2016)

Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism
por: Levi, Sonia, et al.
Publicado: (2015)

Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging
por: Cozzi, Anna, et al.
Publicado: (2019)

Improving growth properties of Corynebacterium glutamicum by implementing an iron‐responsive protocatechuate biosynthesis
por: Thoma, Felix, et al.
Publicado: (2023)

Early occurrence of inspiratory muscle weakness in Parkinson’s disease
por: Baille, Guillaume, et al.
Publicado: (2018)

A Patient with Neuroferritinopathy Presenting with Juvenile-Onset Voice Tremor
por: Park, Chan Wook, et al.
Publicado: (2020)

Regional siderosis: a new challenge for iron chelation therapy
por: Cabantchik, Zvi Ioav, et al.
Publicado: (2013)

Nectar biosynthesis is conserved among floral and extrafloral nectaries
por: Chatt, Elizabeth C, et al.
Publicado: (2021)

Novel Ferritin Light Chain Gene Mutation in a Korean Patient with Neuroferritinopathy
por: Yoon, So Hoon, et al.
Publicado: (2019)

Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy
por: van Hattem, Jessica, et al.
Publicado: (2023)

Prediction of conserved and variable heat and cold stress response in maize using cis-regulatory information
por: Zhou, Peng, et al.
Publicado: (2021)

Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
por: Moonen, Anja J.H., et al.
Publicado: (2021)

Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity
por: Carey, Guillaume, et al.
Publicado: (2023)

Heterozygous nonsense variants in the ferritin heavy-chain gene FTH1 cause a neuroferritinopathy
por: Shieh, Joseph T., et al.
Publicado: (2023)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Ventilatory Dysfunction in Parkinson’s Disease
por: Baille, Guillaume, et al.
Publicado: (2016)

A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits
por: Maccarinelli, Federica, et al.
Publicado: (2015)

Heterozygous Nonsense Variants in the Ferritin Heavy Chain Gene FTH1 Cause a Novel Pediatric Neuroferritinopathy
por: Shieh, Joseph T, et al.
Publicado: (2023)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s Disease
por: Devignes, Quentin, et al.
Publicado: (2021)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder
por: Ganapathy S., Ranjani, et al.
Publicado: (2022)

A multiple ion-uptake phenotyping platform reveals shared mechanisms affecting nutrient uptake by roots
por: Griffiths, Marcus, et al.
Publicado: (2020)

Iron Chelation Resulting in Renal Phosphate Wasting
por: Cheddani, Lynda, et al.
Publicado: (2017)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vm63c4kq3mkroot0g7hls5nm2g